Safety and Efficacy of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
This study assessed the safety and efficacy of canakinumab pre-filled syringes in comparison
to triamcinolone acetonide 40 mg and canakinumab lyophilizate in patients that have frequent
flares of acute gouty arthritis.